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Abstract
Background: In this study, we examined the correlation between excitation-contraction coupling
characteristics and skeletal muscle fibre type by (1) localizing the distribution of dihydropyridine
receptor (DHPR) protein and (2) comparing the effect of DHPR blocker on muscles with different
fibre type composition, in order to better understand the differences between contractile
phenotypes of fibres and to explain the contradictory reports to date on the interaction of
dihydropyridines with skeletal muscle isoform of DHPR.
Results: Histochemical experiments revealed that fluorophore conjugated dihydropyridines stain
selectively the membranes of muscle fibres. The staining was most evident in type IIA fibres. The
major fibre type in gluteus and femoris, revealed by mATPase staining, was IIA (45.0 and 38.1 %,
respectively). In gastrocnemius the content of IIA fibres was 22.7 %. Contraction forces before and
after the addition of blocker for the three muscles investigated were: gluteus 0.075 ± 0.017 N vs.
0.052 ± 0.011 N, femoris 0.045 ± 0.005 N vs. 0.033 ± 0.005 N and gastrocnemius 0.089 ± 0.016 N
vs. 0.075 ± 0.014 N, respectively. The attenuation of contraction force proportional to the cross-
sectional area of the muscle was significantly (P = 0.023) higher in gluteus (28.3 ± 3.5 %) and femoris
(27.6 ± 3.2 %) as compared to gastrocnemius (16.1 ± 2.5 %). However, no significant change in the
control measurements was observed ruling out the possibility of fatigue.
Conclusion: The results indicate that the attenuation of the contraction force was largest in
muscles with a high percentage of type IIA fibres. This supports our finding that the abundance of
dihydropyridine receptors of IIA fibres outnumbers that in the other fibre types. The present data
show that the correlation of density of dihydropyridine receptors can be one of the important
factors influencing the overall contractile properties of the muscle and for its part explain the
contradictory results of previous studies on coupling process.
Background
One of the features characterizing mammalian skeletal
muscle tissue is the structural variability of muscle fibres.
The inclusive properties of skeletal muscle lead to func-
tional diversity of muscle fibres, which has been related to
differences in relative proportions of membrane struc-
tures and to different amounts of contractile proteins [1].
Although the interfibre-type differences are well recog-
nized, very little is known about the characteristics of the
process leading from electrical membrane excitation to
contraction (E-C coupling) related to different cell types.
The first indication of variation in E-C coupling between
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representatives of different fibre types came from studies
using vaseline-gap technique in order to record slow cal-
cium currents and asymmetric charge movement in fast-
and slow-twitch muscles [2]. The results suggested func-
tional and structural differences between fast- and slow-
twitch mammalian muscles with respect to dihydropyrid-
ine receptor (DHPR) density. Recently Goodman et al [3]
provided the first evidence about E-C coupling character-
istics being related to myosin heavy chain based fibre type
and the muscle from which the fibre originated. Our find-
ing about the density of DHPR varying between different
fibre types [4] supports the hypothesis that optimum con-
tractile function of skeletal muscle is related to its fibre
type composition via differences in E-C coupling.
Voltage-dependent dihydropyridine receptors play an
important role in the function of skeletal muscle. As well
known, contraction is initiated by a depolarization of the
transverse tubular (T-tubular) membrane, which in turn
causes calcium to be released from the stores of sarcoplas-
mic reticulum (SR). The DHPR is located in the T-tubule
membrane acting as a voltage sensor. Linked to the ryan-
odine receptor located in the sarcoplasmic reticulum
membrane, this channel protein triggers the intracellular
Ca2+-release via the ryanodine receptor [5]. The DHPR
itself is a heteromultimer composed of 5 subunits; α1 (170
kDa), α2 (140 kDa), β (55 kDa), γ (33 kDa) and δ (24–33
kDa) [6,7]. The pore forming α1 subunit contains the
receptor for dihydropyridines (DHPs) and other calcium
antagonists. DHPs, such as nifedipine, nitrendipine, and
nimodipine, bind to DHP receptor in a specific, saturable
and reversible fashion. In addition, receptors show high
affinity for DHP ligands. The dissociation constant (KD)
for skeletal muscle membranes is usually in the range of
1–10 nM [8]. Dihydropyridines are used clinically as
blockers in the treatment of hypertension and coronary
heart disease [9].
Besides being the voltage sensor for Ca2+ release needed in
E-C coupling, the α1-subunit of the molecule functions
also as a calcium channel [10] giving rise to a slow inward
calcium current [11]. However, DHPR appears to be
unimportant as an ion-conducting channel [12]. Firstly,
the calcium current is activated too slowly to generate con-
traction of the fibre. Second, the contraction continues
even if the extracellular calcium is removed, and finally,
blocking the slow calcium current through the channel
does not prevent contraction. On the other hand, Beam et
al [5] reported a notable increase in the magnitude of
inward calcium current in developing muscle thus impli-
cating an important role of the current in maturation.
In the present study we examined the E-C coupling char-
acteristics of muscles with different dihydropyridine
receptor expression defined by fibre type composition. To
test the hypothesis that muscles with different cell type
compositions, i.e. DHPR quantities, react differently to
calcium channel blocker, we measured contraction forces
of three muscles before and after adding the blocker solu-
tion. We found variation in the activities of muscles
depending on the cell type composition of the muscles.
The findings confirm the previously observed pattern and
elucidate the role of dihydropyridine receptor in muscle
cell contraction.
Results
Myosin heavy chain analysis and fibre typing
In order to analyse the distribution of cell types in the glu-
teus maximus (GLU), rectus femoris (RF) and gastrocne-
mius (GAS) muscles, tissue samples were collected and
subjected to SDS-PAGE. The different muscles of mouse
contained four myosin heavy chain (MHC) isoforms in
the increasing electrophoretic mobility, MHCIIa,
MHCIId, MHCIIb and MHCI (Fig. 1) as compared to
those of rat gastrocnemius muscle (in this report MHC
isoform expressed in fibre is identified by roman numeral
and lower case letter, while the fibre type is identified by
a roman numeral and a corresponding capital letter
according to Hämäläinen and Pette [13]). The distribu-
tion of these myosin heavy chain isoforms differed among
the three muscles studied (Table 1). In GAS, the major iso-
form was MHCIId (35.6 %), expressed together with
smaller amounts of IIb (28.1 %). On the other hand, the
quantity of MHCIIa was smaller (20.6 %). In contrast to
GAS, both GLU and RF were characterized by higher
Electrophoretic separation of myosin heavy chain isoforms Figure 1
Electrophoretic separation of myosin heavy chain 
isoforms. Myosin isoforms of mouse muscles were com-
pared to those of rat gastrocnemius muscle (lane 1). Densi-
togram of each lane is shown above the gel. The muscles 
analysed were m. gastrocnemius (lane 2), m. gluteus (lane 3) 
and m. rectus femoris (lane 4).BMC Physiology 2005, 5:4 http://www.biomedcentral.com/1472-6793/5/4
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Table 1: The proportion of fibre types in different muscles. The fibre type composition of m. rectus femoris, m. gastrocnemius and m. 
gluteus maximus were determined by SDS-PAGE based on electrophoretic separation of myosin heavy chain isoforms, and staining 
for myofibrillar ATPase after acid and alkaline preincubation. IIa, IIb, IId; myosin heavy chain types, IIA, IIB, IID; fibre types. Statistical 
significance of the differences between the corresponding groups (I vs. I, IIa vs. IIA etc.) from the two methods used: NS non 
significant; * P < 0.05; ** P < 0.01; *** P < 0.001.
muscle fibre populations % (SE)
SDS-PAGE m. rectus femoris m. gastrocnemius m. gluteus maximus
I 24.3 (3.0) 15.7 (4.6) 23.2 (3.0)
IIa 27.7 (1.1) 20.6 (3.2) 26.6 (2.9)
IIb 24.3 (2.3) 28.1 (3.1) 15.9 (1.4)
IId 23.7 (1.7) 35.6 (2.2) 34.3 (1.3)
total 100.0 100.0 100.0
mATPase
I 21.1 (2.3) NS 7.6 (1.3) ** 8.0 (2.6) **
IIA 38.1 (1.5) *** 22.7 (3.8) NS 45.0 (0.8) ***
IIB 19.2 (2.3) * 18.2 (1.8) ** 31.1 (3.6) **
IID 21.6 (1.1) NS 51.5 (3.1) *** 15.9 (1.6) ***
total 100.0 100.0 100.0
Characterization of fibre type specificity of dihydropyridine  receptor Figure 2
Characterization of fibre type specificity of dihydro-
pyridine receptor Two subsequent sections of mouse 
musculus gastrocnemius were assayed for DHPR localization 
by fluorescence staining (A) and for fibre type analysis by 
staining for mATPase (B). After preincubation in pH 4.6, type 
IIA displays a relatively low acid stability and is stained most 
lightly (*). The corresponding fibre in (A) is also recognized 
by fluorophore conjugated DHP blocker. The fibre on the 
right of the asterisked fibre shows also fluorescence. The 
intensity is, however, somewhat lower than in the fibre next 
to it and originates probably from the special fibre type 
(hybrid, type IIDA). (C) A control sample preincubated with 
nifedipine. Bar 20 µm.
Effect of nifedipine on contraction force Figure 3
Effect of nifedipine on contraction force. Maximum 
contraction forces of GAS, RF and GLU in proportion to the 
cross-sectional area of the muscle (white), and the average 
responses to 1 µM nifedipine solution (grey) are shown. The 
fatigue control was performed with GAS, RF and GLU in 
physiological salt solution devoid of nifedipine in order to 
control the procedure and to rule out the possibility of 
fatigue. The statistical significance of differences between 
means of contraction forces before and after the addition of 
nifedipine solution is shown by levels (*, P < 0.05; ** P < 0.01, 
paired samples t-test).
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contents of MHCIIa (26.6 % and 27.7 %, respectively),
together with MHCd (34.3 %; 23.7 %) and lower amount
of MHCIIb (15.9 %; 24.3 %). All the muscles contained
also portions of MHCI (GAS: 15.7 %, GLU: 23.2 %, RF:
24.3 %). A statistically significant difference (P < 0.05)
was found in the portion of IIb between GAS and GLU as
well as in IId between GAS and RF. Four fibre types were
also identified in muscle sections stained with mATPase
(Table 1). The major fibre type in GAS was IID (51.5 %).
However, in contrast to the results from SDS-PAGE, IIA
fibre type (22.7 %) outnumbered the IIB (18.2 %). The
most frequent fibre type in both GLU and RF was IIA (45.0
%; 38.1 %), followed by IIB (31.1 %) in GLU and IID
(21.6 %) in RF. There was a statistically significant differ-
ence (P < 0.05) in the portion of IIA between GLU and RF.
In addition, between GAS and RF a significant difference
was found in the proportion of I (P < 0.05) and IID (P <
0.01). Between GAS and GLU a significant difference was
found in proportion of IIA (P < 0.05) and IID (P < 0.01).
To summarise, the significant difference in proportion of
IIA between GAS and RF/GLU is particularly relevant to
the present study.
DHPR expression and correlation to fibre types
We have previously shown that the density of dihydropy-
ridine receptors (L-type calcium channels) in T-tubule
membranes increases markedly during the postnatal
development of mouse skeletal muscle [4]. Furthermore,
the findings showed that the fast oxidative glycolytic
(FOG) fibre type has the most evident appearance of
DHPRs. Fig. 2A shows localization of DHPR in mouse RF
muscle. DHPR is strongly expressed in some muscle fibres
whereas weakly expressed at the membrane of others. The
corresponding control slide, preincubated with nifedipine
resulted in a loss of staining (Fig. 2C). To correlate the
DHPR expression with muscle fibre typing, histochemical
experiments were performed as described. According to
the staining intensity, IIA fibre type corresponds to the
muscle fibres that strongly express DHPRs (Fig. 2B).
Force measurements
GLU, RF and GAS muscles were weighed and the length
and diameter were measured. Table 2 shows some mor-
phological details for the muscles studied. To reveal the
function of L-type calcium channels in muscles with dif-
ferent kinds of cell type distributions, the single twitch
forces of the muscles were measured before and after the
addition of a specific channel blocker nifedipine. Maxi-
mum contraction forces in proportion to the cross-sec-
tional area of the muscle, and the average responses to 1
µM nifedipine solution are shown in Fig. 3. The force pro-
duction of GAS (0.089 ± 0.016 N) was considerably
higher in comparison to the ones of GLU (0.075 ± 0.017
N) and RF (0.045 ± 0.005 N). The effect of nifedipine on
Table 2: A selection of morphological features of different muscles.
mass size
muscle N body (g) muscle (g) length (mm) diameter (mm)
m. rectus femoris (SE) 8 32.13 (1.64) 0.12 (0.01) 11.10 (0.23) 5.20 (0.20)
m. gastrocnemius (SE) 12 31.25 (2.18) 0.15 (0.01) 11.41 (0.31) 5.95 (0.19)
m. gluteus maximus 
(SE)
13 27.50 (1.51) 0.11 (0.01) 12.70 (0.30) 6.61 (0.24)
A force-concentration curve for GAS (∆) and GLU (×) Figure 4
A force-concentration curve for GAS (∆) and GLU 
(×) GLU was also used as a saline standard (❍ ) in order to 
rule out the possibility of fatigue. The x-axis displays the 
increase of nifedipine concentration and the y-axis shows the 
relative force response of the muscles in % of the maximum 
initial value. Values are given as means ± SE (dashed lines for 
GAS). The significance of the decrement of contraction force 
in proportion to the cross-sectional area of the muscle is 
shown by levels (*, P < 0.05; ** P < 0.01, paired samples t-
test) in GLU at nifedipine concentration of 5 µM onwards. N 
= 6 in each measurement.
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contractile force was inhibiting in all the muscles studied.
The  in vitro nifedipine effect on the muscle force
production was determined as the percentage of the
remaining channel mediated contraction force. The weak-
ening of contraction force proportional to the cross-sec-
tional areas of the muscles was significantly (P = 0.023)
higher in GLU (28.3 ± 3.5 %) and RF (27.6 ± 3.2 %) in
comparison to GAS (16.1 ± 2.5 %). Experiments per-
formed in increasing concentrations of nifedipine
resulted in a clear dose-response curve (Fig. 4) and
revealed a decreasing force output as the blocker concen-
tration increased. Furthermore, the decrease was signifi-
cantly smaller in GAS (P < 0.05 at nifedipine
concentration of 5 µM), in comparison to the decrease in
GLU.
Discussion
The cell type composition of a muscle is one of the fea-
tures characterizing the function of the muscle. Type I
fibres are most prevalent in muscles involved in the
maintenance of posture, whereas type II fibres are used for
movements which require high power output. Many ver-
tebrate locomotor muscles are composed of a mixture of
fibre types. Additionally, one muscle fibre may contain
several myosin heavy chain types indicating heterogeneity
at fibril level [14]. The m. gastrocnemius (whole) used in
this study has a high type IIB content whereas both m. rec-
tus femoris and m. gluteus maximus are predominantly
composed of types IIA and IID. The results from myosin
heavy chain analysis and fibre typing are somewhat differ-
ent. The identification of four different fibre types using
histochemical methods is difficult because of the presence
of several types of myosin heavy chains within one single
fibre. Therefore, the MHC analysis is more qualitative. The
correlation of high density of DHPRs with IIA fibres was
stated on the basis of ATPase activity. This was previously
also shown by statistical analysis where fibre size was
additionally taken into account [4].
Nifedipine was used as an antagonist in order to specifi-
cally block the dihydropyridine receptors. Nifedipine is a
dihydropyridine derivative that binds in a specific,
stereoselective and saturable fashion to DHPR. The selec-
tive calcium channel inhibitor prevents the influx of
extracellular calcium through the L-type calcium channel
[15] and also has a clear effect on the contraction activity
of the skeletal muscle fibre. The effects of nifedipine on
depolarization-induced force responses are inhibitory and
dose dependent [16]. As the half life of the blocker is 2 –
6 h, there is enough time to perform reliable
measurements.
By blocking the channel with nifedipine, a clear selective
decrease in the contraction force of the different muscles
studied was observed (Fig. 3). The inhibition percentages
of RF and GLU were, however, significantly higher as com-
pared to that of GAS. This data indicates that the same
concentration of blocker causes a different response
between different muscles. A similar variability is noted
when compared to the cell type composition of the mus-
cles. The muscles with high IIA fibre type content have
strongly reduced contraction force as a result of addition
of a calcium channel blocker. On the other hand, the
effect of a blocker on the muscle with a lower IIA type con-
tent is much weaker. The findings are attributable to the
varying densities of dihydropyridine receptors in muscles.
In GAS, the amount of DHPRs is reduced, likely due to the
low IIA fibre type content. Thus the blocking effect of a
receptor antagonist is weaker as compared to the muscles
with a higher IIA content. Furthermore, the response of
GAS and GLU to the gradual saturation of DHPRs with
nifedipine molecules is different (Fig. 4). Consistently, the
inhibition percentage of the contraction force of GAS
decreased less as compared to GLU. In addition, a con-
stant level of the contraction force was reached sooner in
GAS indicating a complete saturation of the receptors
available.
There are several examples of the divergent behaviour of
the dihydropyridine receptor in skeletal muscle. First,
dihydropyridines are shown to have both stimulatory [17]
and inhibitory [18] effects on excitation-contraction cou-
pling. Furthermore, unlike in cardiac muscle, calcium
release from SR does not require inward current, and as
yet is induced by blockade of dihydropyridine receptors
[19]. However, it is clear that DHPRs are essential in
excitation-contraction coupling since animals with mdg/
mdg mutation, which results in a lack of receptor proteins,
die at birth because of paralysis of the respiratory muscles
[20]. On the other hand, when the α1-subunit is intro-
duced into the nuclei of the dysgenic myotubes, some
cells contract upon an electrical stimulation. Despite of
this, the recovered influx of calcium ions is not necessary
for the contraction since the cells are contracting also even
if the current is blocked with cadmium. Hence calcium
antagonist drugs seem to have very few pharmacologically
relevant actions on skeletal muscle as observed also by
Walsh et al [21]. The role of inward current is still an open
question although it has been suggested that the current is
needed to maintain the calcium stores inside the cell [5]
or for the conditions of activeness of the voltage sensor
[22].
In the present study we report one plausible explanation
for the large variation of the results observed in the behav-
iour of the L-type calcium channels in skeletal muscle. The
uneven density distribution of dihydropyridine receptors
indicates a difference in E-C coupling machinery between
muscle fibre types. In this study, we showed that the dif-
ference is also detectable in the contraction forcesBMC Physiology 2005, 5:4 http://www.biomedcentral.com/1472-6793/5/4
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between muscles of different cell type composition.
Although nifedipine specifically blocks the dihydropyrid-
ine receptor, there could also be other differences in addi-
tion to the density of receptors between the muscles
causing the difference in the contraction forces. A larger
number of different muscles and developmental stages
might clarify the differences in the present results.
Goodman et al [3] provided the first evidence that E-C
coupling characteristics are related to fibre types based on
myosin heavy chain. By measuring depolarization-
induced force responses of skinned single fibres of rat,
they concluded that the optimum force production of a
skeletal muscle is related to its MHC isoform composi-
tion. Although we found no published data on the E-C
coupling phenotype of MHC IIa isoform, the results from
previous studies suggest that the parameters describing
force and velocity properties of a single muscle fibre are
significantly higher in the fast, type IIA and IIB, fibres than
in slow, type I fibres.
Conclusions
Taken together, our results obtained from three different
muscles confirmed that the expression of dihydropyridine
receptor is a fibre type specific character. In addition, the
present data indicate that the density of DHPRs is one
important factor influencing the overall contractile prop-
erties of the muscle. Furthermore, the results of our
experiments point out that when determining the
physiological relevance of DHPRs, it is necessary to com-
pare histochemistry and protein analysis to relevant func-
tional properties such as contraction of the muscle.
Moreover, it is noted, that differences between developing
and adult type of muscle cells may emerge due to the dif-
ferentiation of phenotypes of muscle fibres. In the future
it might be useful to examine the correlation from a larger
number of different muscles, and from muscles of differ-
ent developmental stage.
Methods
Electrophoretic separation of myosin heavy chain isoforms
M. rectus femoris (N = 6), m. gastrocnemius (N = 6) and
m. gluteus maximus (N = 6) from adult mice (strain CD-
1) were removed after the animals were killed by paracer-
vical dislocation in accordance with the Animal Ethics
Committee of the University of Oulu (licence no. 046/
03). The muscles were homogenized in 6 vol of homoge-
nization buffer [62.5 mM Tris-HCl, pH 6.8] and boiled in
sample buffer as previously described for 5 min at a final
protein concentration of 0.5 mg ml-1 [23]. Total protein
was assayed according to the method of Bradford [24].
Myosin heavy chain isoforms were separated by gradient
(5–8 %) sodiumdodecylsulfate polyacrylamide gel
electrophoresis performed at 5°C for 23 h (120 V constant
voltage). The gels were stained with Coomassie Brilliant
Blue. The stained gels were scanned and the separated pro-
tein bands were analysed with FluorS MultiImager pro-
gram (Bio-Rad, USA).
Fibre typing
Serial cross-sections, 8 µm thick, were cut on a cryostat
microtome at -25°C, mounted on cover slips and stained
for myosinATPase (mATPase) with acid preincubation
according to Hämäläinen and Pette [25]. The sections
were preincubated at room temperature for 7 min in
sodium acetate (54.3 mM) – sodium barbital (32.6 mM)
solution adjusted with HCl to pH 4.6. After washing with
CaCl2 (18 mM) and Tris-HCl (199 mM) the sections were
incubated in substrate solution (4.5 mM ATP, 19.5 mM
CaCl2, 116 mM 2-amino-2-methyl-1-propanol; pH 9.4) at
room temperature for 45 min. After incubations in 11 mM
CaCl2, 2% CoCl2, and 10 mM sodium barbital, the colour
was developed in 2% (v/v) ammonium sulphide for 45 s.
After washing with distilled water, the sections were dehy-
drated in ethanol, cleared in xylene and mounted with
DPX. An alkaline preincubation in a solution containing
34 mM 2-amino-2-methyl-1-propanol, 120 mM CaCl2,
adjusted to pH 10.3 with HCl was also used as previously
described by Guth and Samaha [26]. After preincubation
the sections were processed as above. The percentage of
each fibre type in different muscles was calculated with
the use of the LSM 5 PASCAL software 3.2 (Leo, Germany)
for analyzing images.
Fluorescence staining
For fluorescence labelling, RF muscle from mouse was cut
into 8 µm cryostat sections, dried for 30 min and treated
as previously described by Mänttäri et al [4]. The concen-
tration of the high affinity (-)-enantiomer of dihydropyri-
dine was 20 nM. Control samples were preincubated with
10 µM nifedipine in the phosphate buffer for 10 min prior
to the addition of dihydropyridine conjugate.
Force measurements
Adult mice (weighing 23 – 45 g) were killed by paracervi-
cal dislocation, and the pelvic region and right hind limb
were skinned. The muscle of interest (m. rectus femoris,
m. gastrocnemius or m. gluteus maximus) was dissected
out and suspended between a fixed clamp at the base of
an organ bath and a Grass FTO3C (USA) force-displace-
ment transducer. Muscles were maintained in an oxygen-
ated (95% O2 – 5% CO2) physiological saline solution
(+37°C, pH 7.4) containing 137.0 mM NaCl, 2.7 mM
KCl, 1.0 mM MgSO4· 7H2O, 1.8 mM CaCl2, 0.4 mM
NaH2PO4, 12 mM NaHCO3 and 5.5 mM glucose. After an
equilibration period of 2 min, the muscles were
supramaximally stimulated using steel electrode, pulses of
1 ms duration at 80 V (model S44, Grass Instrument Co.)
and muscle length selected to elicit maximal twitch force.
The maximum force of the muscle was measured in seriesBMC Physiology 2005, 5:4 http://www.biomedcentral.com/1472-6793/5/4
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of three stimulus impulses with one minute equilibration
time between the stimulations. Recordings of transducer
output were A/D converted and collected on a computer
at a sample frequency of 1000 Hz.
In order to examine the role of a specific, L-type calcium
channel blocker, the muscles first measured in saline solu-
tion were mounted in a bath containing 1 µM nifedipine
[1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyrid-
inedicarboxylic acid dimethyl ester], equilibrated for 2
min, and assessed as described above i.e. the muscle was
a control in itself. In addition, series of measurements
were made with m. gastrocnemius (N = 6) and m. gluteus
(N = 6) using nifedipine concentration range of 2 – 30
µM. The concentration of the drug was progressively
increased by adding the nifedipine solution to the saline
solution bath. During the experiment, the nifedipine
solutions were maintained in dark to prevent photo-
bleaching. To exclude the possibility of fatigue caused by
successive stimulations, the protocol control measure-
ment was performed similarly devoid of nifedipine.
Statistical analysis
The statistical significance of differences between means
of contraction forces before and after the addition of cal-
cium channel blocker was evaluated by paired samples t-
test. The difference in parameters between the different
types of muscle were analysed with independent samples
t-test for equality of means. A P value of < 0.05 was
accepted as indicative of a significant difference between
the two sets of observations. The significance of differ-
ences between the muscles was evaluated with one way
analysis of variance (normality test passed). The signifi-
cant difference was stated as mentioned above. The values
are presented as the means ± SE. All the statistical analyses
were performed with the SPSS for Windows software.
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